Falk E - Search Results

1

Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study.

Baber U, Mehran R, Sartori S, Schoos MM, Sillesen H, Muntendam P, Garcia MJ, Gregson J, Pocock S, Falk E, Fuster V. Baber U, et al. Among authors: falk e. J Am Coll Cardiol. 2015 Mar 24;65(11):1065-74. doi: 10.1016/j.jacc.2015.01.017. J Am Coll Cardiol. 2015. PMID: 25790876 Free article.

2

Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study.

Sillesen H, Muntendam P, Adourian A, Entrekin R, Garcia M, Falk E, Fuster V. Sillesen H, et al. Among authors: falk e. JACC Cardiovasc Imaging. 2012 Jul;5(7):681-9. doi: 10.1016/j.jcmg.2012.03.013. JACC Cardiovasc Imaging. 2012. PMID: 22789936 Free article.

3

A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study.

Mortensen MB, Fuster V, Muntendam P, Mehran R, Baber U, Sartori S, Falk E. Mortensen MB, et al. Among authors: falk e. J Am Coll Cardiol. 2016 Aug 30;68(9):881-91. doi: 10.1016/j.jacc.2016.05.084. J Am Coll Cardiol. 2016. PMID: 27561760 Free article. Clinical Trial.

4

Negative Risk Markers for Cardiovascular Events in the Elderly.

Mortensen MB, Fuster V, Muntendam P, Mehran R, Baber U, Sartori S, Falk E. Mortensen MB, et al. Among authors: falk e. J Am Coll Cardiol. 2019 Jul 9;74(1):1-11. doi: 10.1016/j.jacc.2019.04.049. J Am Coll Cardiol. 2019. PMID: 31272534 Free article.

5

Why not screen for subclinical atherosclerosis?

Sillesen H, Falk E. Sillesen H, et al. Among authors: falk e. Lancet. 2011 Aug 20;378(9792):645-6. doi: 10.1016/S0140-6736(11)60059-7. Epub 2011 Mar 25. Lancet. 2011. PMID: 21440933 No abstract available.

6

The high-risk plaque initiative: primary prevention of atherothrombotic events in the asymptomatic population.

Falk E, Sillesen H, Muntendam P, Fuster V. Falk E, et al. Curr Atheroscler Rep. 2011 Oct;13(5):359-66. doi: 10.1007/s11883-011-0193-0. Curr Atheroscler Rep. 2011. PMID: 21800090 Free PMC article. Clinical Trial.

7

Peripheral artery disease (PAD) screening in the asymptomatic population: why, how, and who?

Sillesen H, Falk E. Sillesen H, et al. Among authors: falk e. Curr Atheroscler Rep. 2011 Oct;13(5):390-5. doi: 10.1007/s11883-011-0196-x. Curr Atheroscler Rep. 2011. PMID: 21811798 Review.

8

Coronary plaque disruption.

Falk E, Shah PK, Fuster V. Falk E, et al. Circulation. 1995 Aug 1;92(3):657-71. doi: 10.1161/01.cir.92.3.657. Circulation. 1995. PMID: 7634481 Review. No abstract available.

9

The BioImage Study: novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease--study design and objectives.

Muntendam P, McCall C, Sanz J, Falk E, Fuster V; High-Risk Plaque Initiative. Muntendam P, et al. Among authors: falk e. Am Heart J. 2010 Jul;160(1):49-57.e1. doi: 10.1016/j.ahj.2010.02.021. Am Heart J. 2010. PMID: 20598972 Clinical Trial.

10

Reply: "Zero": The New Superhero or Superhero in Training?

Mortensen MB, Fuster V, Mehran R, Baber U, Falk E. Mortensen MB, et al. Among authors: falk e. J Am Coll Cardiol. 2019 Nov 5;74(18):2331-2332. doi: 10.1016/j.jacc.2019.09.001. J Am Coll Cardiol. 2019. PMID: 31672197 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

475 results

Search Page